Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
What to do if you think you have rare case of VITT
What to do if you think you have rare case of VITT
What to do if you think you have rare case of VITT
Standard Video
Actions
Overview
Conceptually Similar Documents
CP123328571 | B.C. reports 2nd case of vaccine-induced condition
CP122904771 | B.C. records first case of rare blood clot related to vaccine
CP120124021 | AstraZeneca COVID-19 vaccine now recommended for Canadian seniors
CP119565630 | What to know about Johnson & Johnson's COVID-19 vaccine
CP123183671 | L'Alberta cesse d'utiliser le vaccin d'AstraZeneca
CP120121621 | AstraZeneca recommandé pour les 65 ans et plus
CP119568721 | Here's what to know about Johnson & Johnson's COVID-19 vaccine
CP118963521 | Le vaccin d'AstraZeneca approuvé au Canada
CP120220160 | Le vaccin AstraZeneca est sûr, selon l'AEM
CP120072421 | Le Canada fait encore confiance à AstraZeneca
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
What to do if you think you have rare case of VITT
Source name:
The Canadian Press
Unique identifier:
CP122883921
Legacy Identifier:
bc44b143254ad43a18ad3c4655f949f3c
Type:
Video
Duration:
2m28s
Dimensions:
1920px × 1080px 75.25 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
5/5/2021 10:01:00 PM
Display aspect ratio:
16:9
Tags
AstraZeneca
blood clots
COVID
COVID-19
Oxford-AstraZeneca
pandemic
vaccine
VITT